Agents Acting on the Renin-Angiotensin System Pathway, Pharmacodynamics

Pathway network for the Agents Acting on the Renin-Angiotensin System Pathway, Pharmacodynamics SuperPath

Sources:
  • PharmGKB
  • WikiPathways
  • Reactome

Ordered by rank within the SuperPath, via the multiplicity of each gene in the constituent pathways

Disorders associated with Agents Acting on the Renin-Angiotensin System Pathway, Pharmacodynamics SuperPath

according to GeneCards Suite gene sharing
#DisorderTypeGenesScore
1C1 inhibitor deficiencyDirect
2Hereditary angioedemaDirect
3Renal tubular dysgenesisEnrichmentACE, AGT, AGTR1, REN10.67
4AngioedemaEnrichmentF12, SERPING16.96
5Angioedema, hereditary, 1EnrichmentF12, SERPING16.49
6Hypertension, essentialEnrichmentAGT, AGTR1, NOS35.96
7Stroke, ischemicEnrichmentACE, NOS34.18
8Microvascular complications of diabetes 3EnrichmentACE3.66
9Complement component 4, partial deficiency ofEnrichmentSERPING13.43
10High molecular weight kininogen deficiencyEnrichmentKNG13.43
11Carboxypeptidase n deficiencyEnrichmentCPN13.43
12Angioedema, hereditary, 3EnrichmentF123.43
13Prekallikrein deficiencyEnrichmentKLKB13.43
14Angioedema, hereditary, 6EnrichmentKNG13.43
15UrticariaEnrichmentF123.43
16Hereditary angioedema with c1inh deficiencyEnrichmentSERPING13.43
17F12-associated cold autoinflammatory syndromeEnrichmentF123.43
18Inherited prekallikrein deficiencyEnrichmentKLKB13.43
19Tubulointerstitial kidney disease, autosomal dominant 4EnrichmentREN3.13
20Factor xii deficiencyEnrichmentF123.13
21Congenital disorder of glycosylation, type iirEnrichmentATP6AP22.90
22Parkinsonism with spasticity, x-linkedEnrichmentATP6AP22.90
23Intellectual developmental disorder, x-linked, syndromic, hedera typeEnrichmentATP6AP22.90
24Hypertension, early-onset, autosomal dominant, with severe exacerbation in pregnancyEnrichmentNR3C22.90
25Pseudohyperaldosteronism type 2EnrichmentNR3C22.90
26Syndromic x-linked intellectual disability hedera typeEnrichmentATP6AP22.90
27Hemorrhage, intracerebralEnrichmentACE2.88
28Hereditary angioedema with normal c1inh not related to f12 or plg variantEnrichmentKNG12.83
29Spinocerebellar ataxia 43EnrichmentMME2.83
30Noonan syndrome 13EnrichmentMAPK12.83
31Congenital membranous nephropathy due to maternal anti-neutral endopeptidase alloimmunizationEnrichmentMME2.83
32Charcot-marie-tooth disease type 2tEnrichmentMME2.83
33Mme-related autosomal dominant charcot marie tooth disease type 2EnrichmentMME2.83
34Pyloric stenosis, infantile hypertrophic, 1EnrichmentNOS12.72
35Aortic aneurysm, familial thoracic 8EnrichmentPRKG12.72
36Plasminogen activator inhibitor-1 deficiencyEnrichmentSERPINE12.72
37Ectodermal dysplasia with facial dysmorphism and acral, ocular, and brain anomaliesEnrichmentRHOA2.72
38Vitamin d-dependent rickets, type 3EnrichmentCYP3A42.72
39Linear hypopigmentation and craniofacial asymmetry with acral, ocular and brain anomaliesEnrichmentRHOA2.72
40RicketsEnrichmentVDR2.72
41Congenital plasminogen activator inhibitor type 1 deficiencyEnrichmentSERPINE12.72
42Camurati-engelmann disease 1EnrichmentTGFB12.60
43Corticosterone methyloxidase type i deficiencyEnrichmentCYP11B22.60
44Corticosterone methyloxidase type ii deficiencyEnrichmentCYP11B22.60
45Pseudohypoaldosteronism, type i, autosomal dominantEnrichmentNR3C22.60
46Inflammatory bowel disease, immunodeficiency, and encephalopathyEnrichmentTGFB12.60
47Camurati-engelmann diseaseEnrichmentTGFB12.60
48Familial hypoaldosteronismEnrichmentCYP11B22.60
49PseudohypoaldosteronismEnrichmentNR3C22.60
50Early-onset familial hypoaldosteronismEnrichmentCYP11B22.60
51Charcot-marie-tooth disease, axonal, type 2tEnrichmentMME2.53
52Hypercalcemia, infantile, 1EnrichmentCYP24A12.42
53Kallikrein, decreased urinary activity ofEnrichmentKLK12.42
54Immunodeficiency, common variable, 12, with autoimmunityEnrichmentNFKB12.42
55Immunodeficiency 127EnrichmentTNF2.42
56Autosomal recessive infantile hypercalcemiaEnrichmentCYP24A12.42
57Common variable immunodeficiency 12EnrichmentNFKB12.42
58Bilirubin metabolic disorderEnrichmentF122.39
59Myocardial infarctionEnrichmentACE2.31
60Psoriatic arthritisEnrichmentTNF2.24
61Migraine without auraEnrichmentTNF2.24
62HypertensionEnrichmentF122.23
63Chromosome 22q11.2 deletion syndrome, distalEnrichmentMAPK12.23
64Alzheimer disease 2EnrichmentNOS32.20
65Pre-eclampsiaEnrichmentNOS32.20
66Hyperaldosteronism, familial, type iEnrichmentCYP11B22.13
67Inflammatory bowel disease 25, autosomal recessiveEnrichmentTGFB12.13
68Il10-related early-onset inflammatory bowel diseaseEnrichmentTGFB12.13
69CakutEnrichmentACE2.12
70Idiopathic achalasiaEnrichmentNOS12.12
71Cerebral malariaEnrichmentTNF2.12
72Pseudomyogenic hemangioendotheliomaEnrichmentSERPINE12.12
73HepatoblastomaEnrichmentREN2.11
74Non-syndromic x-linked intellectual disabilityEnrichmentAGTR22.10
75Vitamin d-dependent rickets, type 2aEnrichmentVDR2.02
76Vascular dementiaEnrichmentTNF2.02
77Hemihyperplasia, isolatedEnrichmentRHOA1.94
78Common variable immunodeficiencyEnrichmentNFKB11.87
79Specific learning disabilityEnrichmentMAPK11.79
80Ciliary dyskinesia, primary, 3EnrichmentNFKB11.72
81AsthmaEnrichmentTNF1.68
82Alzheimer disease, familial, 1EnrichmentNOS31.68
83Pulmonary disease, chronic obstructiveEnrichmentVDR1.61
84Alzheimer's diseaseEnrichmentTNF1.61
85Heart, malformation ofEnrichmentMAPK11.58
86Neuropathy, hereditary motor and sensory, okinawa typeEnrichmentMME1.56
87Cystic fibrosisEnrichmentTGFB11.40
88Hepatocellular carcinomaEnrichmentVDR1.38
89MalariaEnrichmentTNF1.36
90Peripheral nervous system diseaseEnrichmentMME1.34
91NeuropathyEnrichmentMME1.34
92Primary ovarian insufficiencyEnrichmentNOS31.15
93Systemic lupus erythematosusEnrichmentTNF1.14
94Familial thoracic aortic aneurysm and aortic dissectionEnrichmentPRKG11.09
95Autism spectrum disorderEnrichmentNR3C20.89
96MicrocephalyEnrichmentMAPK10.78

Loading...
Loading...
Loading...